You are here

diabetes

Doubling down on diabetes drugs, Eli Lilly invests $450M into Research Triangle Park facility

Medical Marketing and Media

Tue, 01/24/23 - 06:34 pm

drug manufacturing

Tandem Closes Insulin Patch Deal

Medical Devices and Diagnostics Industry

Mon, 01/23/23 - 09:47 pm

Tandem Diabetes

With TheracosBio green light, another SGLT2 inhibitor wades into diabetes arena

Fierce Pharma

Mon, 01/23/23 - 10:52 am

type 2 diabetes

Merck discovers 'root cause' of nitrosamine levels in blockbuster diabetes drugs

Endpoints

Thu, 01/19/23 - 10:20 am

drug manufacturing

Novo Nordisk's GLP-1 for Type II diabetes approved for first-line treatment

Endpoints

Fri, 01/13/23 - 11:10 am

type 2 diabetes

California is latest state to sue drug companies over high insulin prices

Marketwatch

Thu, 01/12/23 - 09:17 pm

Oramed’s oral insulin flunks phase 3 diabetes test, sending stock down 70%

Fierce Biotech

Thu, 01/12/23 - 10:39 am

type 2 diabetes

clinical trials

Could This Drug News Give a Lift to Eli Lilly Stock?

Motley Fool

Mon, 01/2/23 - 06:27 pm

long-acting insulin

Mark Cuban’s next act on drug costs: Tackling insulin

NBC News

Thu, 12/22/22 - 11:02 am

Mark Cuban Cost Plus Drugs

Pfizer advances diabetes, obesity drug hopeful into mid-stage testing

BioPharma Dive

Wed, 12/21/22 - 12:34 pm

Eli Lilly diabetes drugs Mounjaro and Trulicity in short supply, FDA says

Medical Marketing and Media

Mon, 12/19/22 - 10:17 pm

Lilly Plunks Down up to $731M in GPCR Pact with Sosei

BioSpace

Fri, 12/16/22 - 10:27 am

drug development

metabolic disorders

Novo Nordisk comments on role of off-label use in Ozempic shortfall

Medical Marketing and Media

Thu, 12/15/22 - 10:56 am

Dexcom’s Jack Leach discusses preparations for G7 launch next year

Medtech Dive

Thu, 12/15/22 - 10:48 am

continuous glucose monitoring

Lilly and Pfizer fight for new territory in obesity and diabetes

EP Vantage

Thu, 12/15/22 - 10:46 am

‘Diabesity’ marketing set to swell as Novo preps relaunch of weight-loss drug

Medical Marketing and Media

Wed, 12/14/22 - 10:36 am

pharma marketing

Tandem Set for M&A in One of Diabetes Tech Most Eventful Years

Medical Devices and Diagnostics Industry

Tue, 12/13/22 - 11:49 pm

Tandem Diabetes Care

Ypsomed seeks new partner for US insulin pump launch as Lilly quits deal

Medtech Dive

Tue, 12/13/22 - 10:38 am

Lilly gearing up for 'substantial expansion' of diabetes med manufacturing by 2025

Fierce Pharma

Tue, 12/6/22 - 09:00 pm

type 2 diabetes

drug manufacturing

Eli Lilly to double its manufacturing capacity for Mounjaro as it faces financial headwinds going into 2023 — report

Endpoints

Mon, 11/21/22 - 06:34 pm

type 2 diabetes

drug manufacturing

Pages